Trials / Completed
CompletedNCT00225745
Ghrelin Levels in Pancreatic Cancer Patients
Assessment of Plasma Ghrelin Levels in Patients With Pancreatic Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 72 (actual)
- Sponsor
- Dartmouth-Hitchcock Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The primary outcome measure for this study is plasma ghrelin level.
Detailed description
The primary outcome measure for this study is plasma ghrelin level, and the two primary comparison are: * Patients with cachexia versus patients without cachexia * Patients with cachexia versus healthy controls
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood draw | One blood draw prior to first treatment |
Timeline
- Start date
- 2004-04-01
- Primary completion
- 2013-10-01
- Completion
- 2015-09-01
- First posted
- 2005-09-26
- Last updated
- 2015-10-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00225745. Inclusion in this directory is not an endorsement.